Company / Net Income
Coherus Oncology, Inc. Net Income History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$89.8M
FY2019
5-year range
-$238.2M / $89.8M
FY2015-FY2019
Trend
+142.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$238M to $90M over the past 2 years.
Based on SEC 10-K filings.
$90M in FY2019.
Improved from -$238M to $90M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, net income increased 142.9% year-over-year.
- Lowest net income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $89.8M | +142.9% |
| FY2018 | -$209.3M | +12.1% |
| FY2017 | -$238.2M | -173.3% |
| FY2016 | -$87.1M | -62.5% |
| FY2015 | -$53.6M | -62.4% |
| FY2014 | -$33.0M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026